Detection, isolation and characterization of principal synthetic route indicative impurities in verapamil hydrochloride

Scientia Pharmaceutica

Volumn 79, Issue 3, 2011, Pages 555-568

  Srixinivasan, Viswanathan ^a,b   Sivaramakrishnan, Hariharan ^a   Karthikeyan, Balakrishnan ^b  

^a Piramal Enterprises Limited   (India)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

HPLC; Impurity analysis; MS; NMR; Verapamil hydrochloride

Indexed keywords

VERAPAMIL;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG DETERMINATION; DRUG IMPURITY; DRUG ISOLATION; DRUG STRUCTURE; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 80051749769     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1101-19     Document Type: Article

References (17)

1. The Merck Index. 14th ed, USA: Merck & Co,Inc. 2006; 9947.
2. Hardman JG, Limbird LE; eds. Goodman & Gilman's The Pharmacological basis of Therapeutics. 9th ed., McGraw-Hill, NewYork. 1999; 855.
3. Martindale The Extra Pharmacopoeia. 31st ed., Royal Pharmaceutical Society, London. 1996; 961-964.
4. Shaheen N, Mahboob T. Antihypertensive and metabolic effects of verapamil: Role of NA-K-ATPASE and electrolytes homeostasis in male and female rats. Pak J Pharm Sci. 2004; 17: 1-11. PMid:16414592
5. Warmann S, Gohring G, Teichmann B, Geerlings H, Fuchs J. MDRI modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro. J Pediatr Surg. 2002; 37: 1579-1584. doi:10.1053/jpsu.2002.36188
6. Peer TH, Jacob TH. Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache. 2009; 49: 117-125. doi:10.1111/j.1526-4610.2008.01298.x
7. Ewin KJ. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 10th ed., McGraw-Hill, London. 2001; 1007.
8. Lednicer D. The Organic Chemistry Of Drug synthesis. John Wiley & Sons, Inc. New York. 1995; 5: 115.
9. Niveen ALM, Yukihiro K, Akimasa S, Terumichi N, Samia EG, Hassan FA, Micheal EEK. Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis. J Chromatogr A. 2000; 875: 447-453. doi:10.1016/S0021-9673(99)01288-1
10. Dethy JM, Broux SD, Lesne M, Longstreth J, Gilbert P. Stereoselective determination of verapamil and nonverapamil by capillary electrophoresis. J Chromatogr B. 1994; 654: 121-127. doi:10.1016/0378-4347(93)E0455-Y
11. Nafisur R, Nadeem AK, Syed NHA. Optimized and validated spectrophotometric methods for the determination of verapamil hydrochloride in drug formulation. ScienceAsia. 2005; 31: 341-348. doi:10.2306/scienceasia1513-1874.2005.31.341
12. Mohamed W, Fathalla B, Nahed EE, Amina A. Spectrofluorometric determination of verapamil hydrochloride in pharmaceutical preparations and human plasma using organized media: Application to stability studies. J AOAC Int. 2006; 89: 1565-1572. PMid:17225603
13. Pauline ML, Susan JG, Edward GL. High-performance liquid chromatographic method for the assay of verapamil hydrochloride and related compounds in raw material. J Pharm Biomed Anal. 1991; 9: 817-822. doi:10.1016/0731-7085(91)80007-V
14. Valvo L, Alimenti R, Alimonti S, Raimondi S, Foglietta F, Campana F. Development and validation of a liquid chromatographic method for the determination of related substances in verapamil hydrochloride. J Pharm Biomed Anal. 1997; 15: 989-996. doi:10.1016/S0731-7085(96)01923-1
15. Khalil S, Kelzieh A. Determination of verapamil in pharmaceutical formulations using atomic emission. J Pharm Biomed Anal. 2002; 27: 123-131. doi:10.1016/S0731-7085(01)00522-2
16. Xu D, Liu S, Liu Z, Hu X. Determination of verapamil hydrochloride with 12-tungstophophoric acid by resonance rayleigh scattering method coupled to flow injection system. Anal Chim Acta. 2007; 588: 10-15. doi:10.1016/j.aca.2007.01.076
17. British Pharmacopoeia. Published by the Stationery office London, 2009; 2128-2129.